Business

iZafe Group Signs Distribution Agreement with Skand for the Launch of Dosell on the Icelandic Market

STOCKHOLM, SE / ACCESS Newswire / November 20, 2025 / iZafe Group AB (publ.)(STO:IZAFE-B) has signed a distribution agreement with Skand ehf regarding the launch and sales of the medication dispensing robot Dosell in Iceland. The agreement marks an ...

articleIzafe Group AbNovember 20, 20253/company/izafe-group-ab/news/izafe-group-signs-distribution-agreement-with-skand-for-the-launch-of-dosell-on-the-icelandic-market
iZafe Group Signs Distribution Agreement with Skand for the Launch of Dosell on the Icelandic Market

About this update from Izafe Group Ab

[{"type":"text","content":"STOCKHOLM, SE / ACCESS Newswire / November 20, 2025 / iZafe Group AB (publ.)(STO:IZAFE-B) has signed a distribution agreement with Skand ehf regarding the launch and sales of the medication dispensing robot Dosell in Iceland. The agreement marks an important step in iZafe Group's continued Nordic expansion and means that Dosell is now being introduced in another European market with a clear need for safe and automated medication management.","length":448,"tagName":"p"},{"type":"text","content":"Skand is an established player in medical technology and health services in Iceland, with team that has extensive experience in introducing innovative solutions within both the public and private healthcare sectors. Through this partnership, iZafe Group gains a locally rooted distributor with strong reach into professional care providers as well as the consumer market, creating solid conditions for broad and long-term market penetration.","length":441,"tagName":"p"},{"type":"text","content":"As part of the agreement, Skand has placed an initial order of 300 Dosell units, with delivery scheduled during 2026. This volume is expected to generate an annual recurring revenue (ARR) of approximately SEK 2-3 million when fully activated, depending on the distribution between B2B and B2C.","length":293,"tagName":"p"},{"type":"text","content":"Iceland is characterized by a high degree of digitalization and a strong focus on patient safety and efficient care processes. A recent analysis estimates that around 8,700 people in Iceland receive their medications in pouch packaging, corresponding to just over 13% of the country's elderly population.","length":308,"tagName":"p"},{"type":"text","content":"Skand has developed a launch plan that combines implementation within healthcare and home care with initiatives aimed at the consumer market. This two-track strategy enables Dosell to be introduced broadly and scalably in Iceland without depending on a single market channel.","length":275,"tagName":"p"},{"type":"text","content":"Public healthcare and home careThe launch begins with selected collaborations within healthcare and home care to establish local reference cases and demonstrate the quality and efficiency gains Dosell provides. The focus is on improved adherence, increased safety and reduced workload for care staff.","length":301,"tagName":...

More updates from Izafe Group Ab

iZafe Group ABIcelandmedication managementSkanddistribution agreementPublic healthcareconsumer marketiZafe Group